Medical Abortion Self-Confirmation (MASC)

Not Applicable

Completed

• Conditions: Medical Abortion

• Registration Number: NCT03148587
• Lead Sponsor: Stanford University

Brief Summary

This study aims to investigate the ability of participants to perform and accurately interpret the multi-level pregnancy test and the low sensitivity pregnancy test following medication abortion, without routine provider contact.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-04-27
• Study Start: 2017-05-01
• Study First Submitted QC: 2017-05-08
• Study First Posted: 2017-05-11
• Primary Completion: 2018-05-31
• Study Completion: 2018-05-31
• Status Verified: 2019-06
• Last Update Submitted: 2019-06-05
• Last Update Posted: 2019-06-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 88

Inclusion Criteria

• Gestational age of less than or equal to 63 days
• English speaking
• Determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria
• In the judgement of the site investigator, she is capable of giving informed consent and she has signed the study informed consent or assent form

Exclusion Criteria

• Allergy to mifepristone and/or misoprostol
• Non-english speaking
• Inability to access internet

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Correct interpretation of pregnancy test	4 weeks after taking medication abortion medication, mifepristone

Trial Locations

Locations (1)

Stanford Health Care; 🇺🇸 Stanford, California, United States